Pharmaceutical Manufacturing & Supply – Moxifloxacin Hydrochloride Tablets

The contract involves the manufacturing and supply of FDA-approved Moxifloxacin Hydrochloride Tablets, specifically tailored for pharmaceutical use and adhering to federal pharmaceutical and defense logistics standards. The procurement is managed by the Medical Supply Chain Pharm FSA under the Department of Defense, with the place of performance designated as Fort Bragg, ZIP code 28310. The contract is classified as a subcontract under the NAICS code 325412, which corresponds to pharmaceutical manufacturing. The solicitation was posted on May 17, 2026, with a response deadline set for May 26, 2026. Although the solicitation number and point of contact are not provided, the contract requires strict compliance with regulations governing FDA-approved medications and defense supply chain logistics. The emphasis on quality and regulatory adherence underscores the government’s intent to secure reliable pharmaceutical supplies for military or related medical applications.